Bessemer Group’s Twist Bioscience TWST Stock Holding History

Bessemer Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21K	Hold	210	–	–	﹤0.01%	1993
2026 Q1	$10K	Hold	210	–	–	﹤0.01%	2124
2025 Q4	$7K	Hold	210	–	–	﹤0.01%	2201
2025 Q3	$6K	Buy	210 +38	+22%	+$1.15K	﹤0.01%	2116
2025 Q2	$6K	Hold	172	–	–	﹤0.01%	1991
2025 Q1	$7K	Buy	172 +32	+23%	+$1.44K	﹤0.01%	1920
2024 Q4	$7K	Hold	140	–	–	﹤0.01%	1924
2024 Q3	$6K	Buy	+140	New	+$6.66K	﹤0.01%	1881
2023 Q3	–	Sell	-521	Closed	-$11K	–	2344
2023 Q2	$11K	Buy	+521	New	+$7.8K	﹤0.01%	1641
2020 Q3	–	Sell	-46,800	Closed	-$2.12M	–	1660
2020 Q2	$2.12M	Buy	46,800 +25,700	+122%	+$922K	0.01%	461
2020 Q1	$645K	Buy	+21,100	New	+$567K	﹤0.01%	718

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bessemer Group's TWST Position: Q2 2026 in Review

Bessemer Group held its Twist Bioscience (TWST) position steady in Q2 2026 at 210 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Bessemer Group first reported a position in TWST in Q1 2020 and has held it in 11 quarters since. The position peaked at $2.12M in Q2 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Bessemer Group held 210 shares of Twist Bioscience worth $21K as of Q2 2026.
Bessemer Group left its Twist Bioscience share count unchanged in Q2 2026.
Twist Bioscience made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1993 holding.
Bessemer Group first reported a position in Twist Bioscience in Q1 2020 and has held it in 11 quarters since.
Bessemer Group's Twist Bioscience position peaked at $2.12M in Q2 2020.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.